Literature DB >> 16620970

Production of vascular endothelial growth factor in T-cell prolymphocytic leukemia.

Toshie Ogasawara1, Chisako Narita, Kiyotaka Kawauchi.   

Abstract

We describe a 79-year-old man who had massive pleural effusion and a proliferation of prolymphocytic leukemia cells in the peripheral blood, bone marrow, and pleural effusion fluid. Immunophenotyping of leukemia cells revealed either CD3+CD4+CD8-CD25+ or CD3+CD4+CD8+CD25+. The antibody against human T-cell lymphotropic virus type I was negative. A diagnosis of T-PLL was made. The level of VEGF in the plasma or pleural effusion fluid was very high. Moreover, polymerase chain reaction analysis demonstrated an expression of VEGF mRNA in the leukemia cells, indicating a production of VEGF from leukemia cells and its involvement in the pathogenesis of T-PLL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16620970     DOI: 10.1016/j.leukres.2006.02.029

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  T-cell prolymphocytic leukemia in Japan: is it a variant?

Authors:  Junichi Kameoka; Naoto Takahashi; Hideyoshi Noji; Kazunori Murai; Katsushi Tajima; Yoshihiro Kameoka; Shinji Sato; Tsutomu Shichishima; Yoji Ishida; Hideo Harigae; Kenichi Sawada
Journal:  Int J Hematol       Date:  2012-04-24       Impact factor: 2.490

2.  TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.

Authors:  Akihiko Yokohama; Akio Saitoh; Hirotaka Nakahashi; Takeki Mitsui; Hiromi Koiso; Yoshitora Kim; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Takahiro Jimbo; Kayoko Murayama; Tohru Sakura; Hirokazu Murakami; Masamitsu Karasawa; Yoshihisa Nojima; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2011-12-23       Impact factor: 2.490

3.  Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line.

Authors:  Erian H Girgis; John P Mahoney; Rafaat H Khalil; Magdi R Soliman
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.